 Lisa Hall-Anderson
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Untranslated | 14 | 2014 | 87 | 2.910 |
Why?
| | X Chromosome Inactivation | 9 | 2013 | 37 | 1.670 |
Why?
| | Chromosomes, Human, X | 8 | 2011 | 27 | 1.320 |
Why?
| | Chromosomes, Mammalian | 2 | 2014 | 22 | 0.760 |
Why?
| | Cell Line | 9 | 2013 | 1755 | 0.670 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2014 | 64 | 0.670 |
Why?
| | Chromatin | 4 | 2009 | 389 | 0.660 |
Why?
| | Euchromatin | 1 | 2014 | 9 | 0.640 |
Why?
| | RNA | 4 | 2013 | 285 | 0.640 |
Why?
| | Interphase | 1 | 2014 | 62 | 0.630 |
Why?
| | Genome, Human | 2 | 2011 | 133 | 0.550 |
Why?
| | Dosage Compensation, Genetic | 5 | 2013 | 20 | 0.510 |
Why?
| | Embryonic Stem Cells | 2 | 2009 | 107 | 0.500 |
Why?
| | Cell Nucleus | 6 | 2014 | 503 | 0.500 |
Why?
| | Cell Differentiation | 2 | 2008 | 1053 | 0.490 |
Why?
| | Gene Silencing | 8 | 2013 | 259 | 0.470 |
Why?
| | Epigenesis, Genetic | 2 | 2009 | 195 | 0.460 |
Why?
| | Genomic Imprinting | 2 | 2010 | 31 | 0.430 |
Why?
| | X Chromosome | 2 | 2010 | 38 | 0.430 |
Why?
| | Chromosomes | 1 | 2009 | 90 | 0.430 |
Why?
| | Chromosome Painting | 2 | 2003 | 6 | 0.390 |
Why?
| | Protein-Serine-Threonine Kinases | 1 | 2009 | 325 | 0.380 |
Why?
| | RNA Precursors | 1 | 2006 | 84 | 0.360 |
Why?
| | Ribonucleoproteins | 1 | 2006 | 98 | 0.340 |
Why?
| | RNA, Nuclear | 1 | 2003 | 10 | 0.320 |
Why?
| | Stem Cells | 1 | 2005 | 204 | 0.310 |
Why?
| | Translocation, Genetic | 1 | 2002 | 53 | 0.290 |
Why?
| | Chromosomes, Human | 1 | 2002 | 28 | 0.280 |
Why?
| | In Situ Hybridization, Fluorescence | 5 | 2013 | 116 | 0.280 |
Why?
| | Nuclear Proteins | 2 | 2006 | 693 | 0.270 |
Why?
| | Transcription Factors | 4 | 2013 | 1212 | 0.260 |
Why?
| | Humans | 20 | 2014 | 33675 | 0.250 |
Why?
| | Mice | 9 | 2014 | 7520 | 0.220 |
Why?
| | Transcription, Genetic | 5 | 2014 | 795 | 0.220 |
Why?
| | Animals | 11 | 2014 | 14889 | 0.210 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 1257 | 0.210 |
Why?
| | Fibroblasts | 3 | 2008 | 292 | 0.180 |
Why?
| | Female | 11 | 2010 | 18522 | 0.180 |
Why?
| | BRCA1 Protein | 2 | 2007 | 28 | 0.170 |
Why?
| | Heterochromatin | 4 | 2007 | 47 | 0.170 |
Why?
| | Sex Chromatin | 3 | 2013 | 10 | 0.160 |
Why?
| | Hybrid Cells | 1 | 2014 | 19 | 0.160 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 13 | 0.160 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2013 | 24 | 0.150 |
Why?
| | Down Syndrome | 1 | 2013 | 29 | 0.150 |
Why?
| | RNA Interference | 3 | 2013 | 510 | 0.140 |
Why?
| | Transgenes | 2 | 2009 | 120 | 0.130 |
Why?
| | Mothers | 1 | 2010 | 95 | 0.120 |
Why?
| | Mediator Complex | 1 | 2009 | 11 | 0.120 |
Why?
| | Protein Phosphatase 1 | 1 | 2009 | 12 | 0.120 |
Why?
| | Male | 8 | 2013 | 17016 | 0.110 |
Why?
| | Indoles | 1 | 2009 | 75 | 0.110 |
Why?
| | DNA | 1 | 2013 | 621 | 0.110 |
Why?
| | Sulfonamides | 1 | 2009 | 75 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2013 | 539 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2009 | 331 | 0.110 |
Why?
| | Inflammation | 1 | 2013 | 659 | 0.110 |
Why?
| | Macrophages | 1 | 2013 | 733 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 129 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2010 | 271 | 0.110 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 48 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 283 | 0.100 |
Why?
| | Cell Aging | 1 | 2008 | 77 | 0.100 |
Why?
| | Cell Cycle | 1 | 2009 | 341 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 85 | 0.100 |
Why?
| | Genes, X-Linked | 1 | 2006 | 9 | 0.090 |
Why?
| | Dinucleotide Repeats | 1 | 2006 | 5 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2008 | 237 | 0.090 |
Why?
| | Spliceosomes | 1 | 2006 | 45 | 0.090 |
Why?
| | Azacitidine | 1 | 2005 | 6 | 0.090 |
Why?
| | Embryo Research | 1 | 2005 | 5 | 0.090 |
Why?
| | Teratogens | 1 | 2005 | 7 | 0.090 |
Why?
| | Models, Molecular | 1 | 2009 | 886 | 0.090 |
Why?
| | Aneuploidy | 1 | 2005 | 28 | 0.090 |
Why?
| | Intranuclear Inclusion Bodies | 1 | 2004 | 7 | 0.080 |
Why?
| | RNA Splicing | 1 | 2006 | 142 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2002 | 379 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2004 | 73 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2007 | 676 | 0.080 |
Why?
| | Cell Nucleolus | 1 | 2004 | 57 | 0.080 |
Why?
| | Evolution, Molecular | 1 | 2006 | 217 | 0.080 |
Why?
| | Carcinoma, Embryonal | 1 | 2003 | 4 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 689 | 0.080 |
Why?
| | Dactinomycin | 1 | 2003 | 13 | 0.080 |
Why?
| | Gene Expression | 2 | 2003 | 613 | 0.080 |
Why?
| | Klinefelter Syndrome | 1 | 2002 | 7 | 0.070 |
Why?
| | Turner Syndrome | 1 | 2002 | 12 | 0.070 |
Why?
| | Karyotyping | 1 | 2002 | 40 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 482 | 0.070 |
Why?
| | MicroRNAs | 1 | 2008 | 458 | 0.070 |
Why?
| | Acetylation | 1 | 2002 | 100 | 0.070 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2003 | 153 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 362 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2003 | 379 | 0.060 |
Why?
| | Base Sequence | 1 | 2002 | 1259 | 0.060 |
Why?
| | DNA Methylation | 2 | 2013 | 171 | 0.060 |
Why?
| | Signal Transduction | 1 | 2008 | 2280 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2003 | 1275 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2013 | 658 | 0.050 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2013 | 10 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 54 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 2013 | 81 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2013 | 36 | 0.040 |
Why?
| | Models, Immunological | 1 | 2013 | 88 | 0.040 |
Why?
| | Macrophage Activation | 1 | 2013 | 99 | 0.040 |
Why?
| | DNA Probes | 1 | 2013 | 38 | 0.040 |
Why?
| | Oligonucleotide Probes | 1 | 2013 | 43 | 0.040 |
Why?
| | Neurogenesis | 1 | 2013 | 32 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2013 | 50 | 0.040 |
Why?
| | Cytosol | 1 | 2013 | 134 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2013 | 205 | 0.030 |
Why?
| | Transfection | 2 | 2004 | 640 | 0.030 |
Why?
| | Animals, Congenic | 1 | 2010 | 4 | 0.030 |
Why?
| | Embryo Loss | 1 | 2010 | 9 | 0.030 |
Why?
| | Fathers | 1 | 2010 | 18 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 424 | 0.030 |
Why?
| | Blastocyst | 1 | 2010 | 51 | 0.030 |
Why?
| | Cytokines | 1 | 2013 | 716 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 104 | 0.030 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 2009 | 16 | 0.030 |
Why?
| | Adult | 1 | 2002 | 9529 | 0.030 |
Why?
| | Pluripotent Stem Cells | 1 | 2009 | 45 | 0.030 |
Why?
| | Ribonuclease III | 1 | 2008 | 73 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 125 | 0.030 |
Why?
| | Genes, BRCA1 | 1 | 2007 | 12 | 0.030 |
Why?
| | Fibrosarcoma | 1 | 2007 | 11 | 0.030 |
Why?
| | Doxycycline | 1 | 2007 | 25 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2010 | 960 | 0.020 |
Why?
| | Gene Deletion | 1 | 2008 | 239 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2007 | 183 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 129 | 0.020 |
Why?
| | DNA Damage | 1 | 2008 | 236 | 0.020 |
Why?
| | Models, Genetic | 1 | 2007 | 226 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 294 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2006 | 207 | 0.020 |
Why?
| | Diploidy | 1 | 2004 | 9 | 0.020 |
Why?
| | Leupeptins | 1 | 2004 | 17 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 13 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2006 | 246 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2007 | 771 | 0.020 |
Why?
| | Homozygote | 1 | 2004 | 98 | 0.020 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 35 | 0.020 |
Why?
| | Heterozygote | 1 | 2004 | 114 | 0.020 |
Why?
| | Histones | 1 | 2007 | 351 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 861 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2008 | 1821 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2004 | 162 | 0.020 |
Why?
| | Hela Cells | 1 | 2004 | 485 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 216 | 0.020 |
Why?
| | Cattle | 1 | 2003 | 281 | 0.020 |
Why?
| | Rats | 1 | 2004 | 1783 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2004 | 1626 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 1018 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2002 | 519 | 0.010 |
Why?
|
|
Hall-Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|